Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 The U.S. FDA has approved a new drug application - Nutraceuticals World

What are you searching for?

Sign in

The U.S. FDA has approved a new drug application

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

The U.S. FDA has approved a new drug application submitted by the Ross Products Division of Abbott Laboratories for Omacor (omega 3 acid ethyl esters) capsules as an adjunct to the diet to reduce triglyceride levels in adult patients with triglyceride levels >500 mg/dL. The product description notes that it is a combination of ethyl esters of eicosapentanoic acid (EPA-approximately 465 mg) and docosahexanoic acid (DHA-approximately 375 mg).

—NPI Center’s Daily News, 11/18/04

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters